Summary: This study examined the effectiveness of terminal branches portal vein embolization (TBPVE) for the treatment of patients with hepatocellular carcinoma (liver cancer; HCC) with insufficient future liver remnant.
Summary: The aim of this study was to investigate the current hospital visits and hepatocarcinogenesis status of patients who received daclatasvir plus asunaprevir treatment (DCV+ASV) to determine whether or not appropriate follow-up was being performed for patients treated for chronic hepatitis C virus infection.
Summary: This study investigated the risk of hepatocellular carcinoma (liver cancer; HCC) from treatment with dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors) in patients with diabetes mellitus (DM) and chronic hepatitis C (HCV) infection.
Summary: This review of the literature evaluated the safety and effectiveness of sorafenib combined with transcatheter arterial chemoembolization (TACE) in the treatment of patients with advanced hepatocellular carcinoma (liver cancer; HCC).
Summary: This case report describes a 36-year-old woman with recurrent hepatocellular carcinoma (liver cancer) after liver transplantation treated with multimodal and systemic therapy with cabozantinib.
Summary: This study compared the outcomes of modified procedures for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in the treatment of patients with large liver carcinoma.